← All patents

US20160030457A1

Tumor-selective combination therapy

University of Texas System

Abstract

The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Paul J. Hergenrother
Priority date
April 09, 2013
Filing date
April 08, 2014
Publication date
February 04, 2016
Language
en
Metadata fetched
August 29, 2026 00:23